TY - JOUR T1 - Rare and <em>de novo</em> variants in 827 congenital diaphragmatic hernia probands implicate <em>LONP1</em> and <em>ALYREF</em> as new candidate risk genes JF - medRxiv DO - 10.1101/2021.06.01.21257928 SP - 2021.06.01.21257928 AU - Lu Qiao AU - Le Xu AU - Lan Yu AU - Julia Wynn AU - Rebecca Hernan AU - Xueya Zhou AU - Christiana Farkouh-Karoleski AU - Usha S. Krishnan AU - Julie Khlevner AU - Aliva De AU - Annette Zygmunt AU - Timothy Crombleholme AU - Foong-Yen Lim AU - Howard Needelman AU - Robert A. Cusick AU - George B. Mychaliska AU - Brad W. Warner AU - Amy J. Wagner AU - Melissa E. Danko AU - Dai Chung AU - Douglas Potoka AU - Przemyslaw Kosiński AU - David J. McCulley AU - Mahmoud Elfiky AU - Kenneth Azarow AU - Elizabeth Fialkowski AU - David Schindel AU - Samuel Z. Soffer AU - Jane B. Lyon AU - Jill M. Zalieckas AU - Badri N. Vardarajan AU - Gudrun Aspelund AU - Vincent P. Duron AU - Frances A. High AU - Xin Sun AU - Patricia K. Donahoe AU - Yufeng Shen AU - Wendy K. Chung Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/04/2021.06.01.21257928.abstract N2 - Congenital diaphragmatic hernia (CDH) is a severe congenital anomaly that is often accompanied by other anomalies. Although the role of genetics in the pathogenesis of CDH has been established, only a small number of disease genes have been identified. To further investigate the genetics of CDH, we analyzed de novo coding variants in 827 proband-parent trios and confirmed an overall significant enrichment of damaging de novo variants, especially in constrained genes. We identified LONP1 (Lon Peptidase 1, Mitochondrial) and ALYREF (Aly/REF Export Factor) as novel candidate CDH genes based on de novo variants at a false discovery rate below 0.05. We also performed ultra-rare variant association analyses in 748 cases and 11,220 ancestry-matched population controls and identified LONP1 as a risk gene contributing to CDH through both de novo and ultra-rare inherited largely heterozygous variants clustered in the core of the domains and segregating with CDH in familial cases. Approximately 3% of our CDH cohort was heterozygous with ultra-rare predicted damaging variants in LONP1 who have a range of clinical phenotypes including other anomalies in some individuals and higher mortality and requirement for extracorporeal membrane oxygenation. Mice with lung epithelium specific deletion of Lonp1 die immediately after birth and have reduced lung growth and branching that may at least partially explain the high mortality in humans. Our findings of both de novo and inherited rare variants in the same gene may have implications in the design and analysis for other genetic studies of congenital anomalies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe whole genome sequencing data were generated through NIH Gabriella Miller Kids First Pediatric Research Program (X01HL132366, X01HL136998, X01HL155060). This work was supported by NIH grants R01HD057036 (L.Y., J.W., W.K.C.), R03HL138352 (A.K., W.K.C., Y.S.), R01GM120609 (H.Q., Y.S.), UL1 RR024156 (W.K.C.) 1P01HD068250 (P.K.D, F.A.H., J.M.W., W.K.C., Y.S., J.M.Z, D.J.M, X.S.) and NSFC81501295 (L.Y.). Additional funding support was provided by grants from CHERUBS, CDHUK, and the National Greek Orthodox Ladies Philoptochos Society, Inc. and generous donations from the Williams Family, Wheeler Foundation, Vanech Family Foundation, Larsen Family, Wilke Family and many other families. Whole genome sequencing data can be obtained from dbGAP through accession phs001110. WHICAP study is supported by funding from NIA RF1AG054023 (B.N.V.). Biogen Inc provided support for whole-exome sequencing for the WHICAP cohort.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All studies were approved by the Columbia University institutional review board (IRB), serving as the central site. Each participating site also procured approval from their local IRB and signed informed consent was obtained. Ethical approval was obtained from the following participating institutions: Boston Children’s Hospital/Massachusetts General Hospital, Washington University, Cincinnati Children's Hospital Medical Center, Children’s Hospital &amp; Medical Center of Omaha, University of Michigan, Monroe Carell Jr. Children’s Hospital, Northwell Health, Oregon Health &amp; Science University, Legacy Research Institute, University of Texas Southwestern, Children’s Hospital of Wisconsin, and Children’s Hospital of Pittsburgh.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll public data from databases and studies were described in the manuscript. The genetic data is accessible through the Diaphragmatic Hernia Research &amp; Exploration; Advancing Molecular Science study (DHREAMS, http://www.cdhgenetics.com/) after necessary clearances; please contact author Wendy K. Chung for more details. The SPARK dataset used in this analysis is preparing to publish and has been given to the Simons Foundation Autism Research Initiative (SRARI) for public distribution. Scientists wishing to access the data set can do so through application to SFARI. The WHICAP dataset analyzed during the current study are available via contact with Badri N. Vardarajan. ER -